In contrast, either no or a minimal decrease in the number of adenomas and carcinomas was observed in the small intestine of APCmin/+ mice treated with COX-2 or single EP2 or EP4 PGE2 receptor inhibitors. Here, PTGS2 is linked to carcinoma.